Recent research on graphene oxide may enhance our ability to fight infections acquired from hospitals and other places. Researchers from the Università Cattolica del Sacro Cuore in Rome are analyzing graphene oxide in the hope of successfully developing bacteria-killing medical devices and catheters in the near future. Bacteria can be killed by coating all surgical equipment with the carbon-based compounsd. This will result in faster recovery times, reducing the number of post-operative infections, and reducing the requirement for antibiotics.
Biopsies are a gold standard for definitively diagnosing diseases like cancer. Usually, doctors can only take two-dimensional snapshots of the tissue, and they're limited in their ability to measure the protein levels that might better explain a diagnosis.
Researchers at The Hebrew University of Jerusalem have developed a nanotechnology-based delivery system containing a protective cellular pathway inducer that activates the body's natural defense against free radicals efficiently, a development that could control a variety of skin pathologies and disorders.
Osteosarcoma is a cancer present in the bones of adolescents and children. Considered an aggressive cancer, Osteosarcoma has only a 15 per cent, five-year survival rate when detected in an advanced metastatic stage. Every year in the US there are about 800 new cases of osteosarcoma with no suitable treatment.
Keywords such as nano-, personalized-, or targeted medicine sound like bright future. What most people do not know, is that nanomedicines can cause severe undesired effects for actually being too big! Those modern medicines easily achieve the size of viruses which the body potentially recognizes as foreign starting to defend itself against - a sometimes severe immune response unfolds.
NanoViricides, Inc. (the "Company") announced today that information on its novel, proprietary anti-virus platform technology has been published in the book "Handbook of Clinical Nanomedicine, Vol. 1. Nanoparticles, Imaging, Therapy, and Clinical Applications", a CRC Press publication. The chapter entitled "Nanoviricides: Targeted Anti-Viral Nanomaterials" provides an in-depth presentation of the NanoViricides platform technology, evidence for how nanoviricides® are believed to act plus dramatic results of nanoviricides specifically targeting certain viral diseases, such as Influenza.
A team of researchers from Virginia Commonwealth University have formulated a novel method to examine DNA molecules. Their research paper titled, “Infrared laser heating applied to nanopore sensing for DNA duplex analysis,” discusses the method for improved forensic DNA workflows to gain much faster and precise identification. The paper has been published in the Analytical Chemistry journal, and was available online from 19th February.
The aim of chemotherapy should be to kill cancer cells without the side effect of hair falling out. A team of researchers from the University of Toronto have developed a novel molecular delivery system, which has the capability to ensure that chemotherapy drugs reach their target without major collateral damage.
A portable and low-cost diagnostic device has been developed at EPFL. This microfluidic platform, which has been tested with Ebola, requires no bulky equipment. It is thus ideally suited for use in remote regions.
Researchers at the University of Michigan Kellogg Eye Center have developed a new nanoparticle that uses a tumor cell's protective mechanism against itself -- short-circuiting tumor cell metabolism and killing tumor cells.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.